Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 31;71(11):e718-e725.
doi: 10.1093/cid/ciaa435.

Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility

Massimo Pacilli  1 , Janna L Kerins  1 , Whitney J Clegg  1 , Kelly A Walblay  1 , Hira Adil  1 , Sarah K Kemble  1 , Shannon Xydis  1 , Tristan D McPherson  1   2 , Michael Y Lin  3 , Mary K Hayden  3 , Mary Carl Froilan  3 , Elizabeth Soda  4   5 , Angela S Tang  4 , Ann Valley  6 , Kaitlin Forsberg  7 , Paige Gable  5 , Heather Moulton-Meissner  5 , D Joseph Sexton  7 , Kara M Jacobs Slifka  5 , Snigdha Vallabhaneni  5 , Maroya Spalding Walters  5 , Stephanie R Black  1
Affiliations

Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility

Massimo Pacilli et al. Clin Infect Dis. .

Abstract

Background: Since the identification of the first 2 Candida auris cases in Chicago, Illinois, in 2016, ongoing spread has been documented in the Chicago area. We describe C. auris emergence in high-acuity, long-term healthcare facilities and present a case study of public health response to C. auris and carbapenemase-producing organisms (CPOs) at one ventilator-capable skilled nursing facility (vSNF-A).

Methods: We performed point prevalence surveys (PPSs) to identify patients colonized with C. auris and infection-control (IC) assessments and provided ongoing support for IC improvements in Illinois acute- and long-term care facilities during August 2016-December 2018. During 2018, we initiated a focused effort at vSNF-A and conducted 7 C. auris PPSs; during 4 PPSs, we also performed CPO screening and environmental sampling.

Results: During August 2016-December 2018 in Illinois, 490 individuals were found to be colonized or infected with C. auris. PPSs identified the highest prevalence of C. auris colonization in vSNF settings (prevalence, 23-71%). IC assessments in multiple vSNFs identified common challenges in core IC practices. Repeat PPSs at vSNF-A in 2018 identified increasing C. auris prevalence from 43% to 71%. Most residents screened during multiple PPSs remained persistently colonized with C. auris. Among 191 environmental samples collected, 39% were positive for C. auris, including samples from bedrails, windowsills, and shared patient-care items.

Conclusions: High burden in vSNFs along with persistent colonization of residents and environmental contamination point to the need for prioritizing IC interventions to control the spread of C. auris and CPOs.

Keywords: Candida; communicable diseases; emerging; fungal; infection control.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
vSNF-A ventilator-capable unit Candida auris colonization status, January 2018 to October 2018. Abbreviations: PPS, point prevalence survey; vSNF, ventilator-capable skilled nursing facility.
Figure 2.
Figure 2.
Resident with ≥2 PPS Candida auris testing results: vSNF-A, January to October 2018. Abbreviations: PPS, point prevalence survey; vSNF, ventilator-capable skilled nursing facility.
Figure 3.
Figure 3.
vSNF-A ventilator-capable unit Candida auris and CPO prevalence, January to October 2018. Abbreviations: CPO, carbapenemase-producing organism; vSNF, ventilator-capable skilled nursing facility.
Figure 4.
Figure 4.
Resident Candida auris (C. auris) and CPO colonization status and room assignment: vSNF-A ventilator-capable unit, October 2018. C. auris prevalence, 71% (49 out of 69); CPO prevalence, 61% (42 out of 69). Abbreviations: CPO, carbapenemase-producing organism; vSNF, ventilator-capable skilled nursing facility.
See this image and copyright information in PMC

References

    1. Vallabhaneni S, Kallen A, Tsay S, Chow N, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep 2016; 65:1234–7. - PubMed
    1. Tsay S, Welsh RM, Adams EH, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities—United States, June 2016–May 2017. MMWR Morb Mortal Wkly Rep 2017; 66:514–5. - PMC - PubMed
    1. Adams E, Quinn M, Tsay S, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis 2018; 24:1816–24. - PMC - PubMed
    1. Fisch J, Lansing B, Wang L, et al. New acquisition of antibiotic-resistant organisms in skilled nursing facilities. J Clin Microbiol 2012; 50:1698–703. - PMC - PubMed
    1. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D’Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56:1276–80. - PubMed

Publication types